Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company.
A number of brokerages have recently weighed in on STVN. Bank of America lifted their price target on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, December 13th. Morgan Stanley reaffirmed an “equal weight” rating and set a $23.00 target price (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Finally, Wolfe Research began coverage on shares of Stevanato Group in a report on Friday, December 13th. They set an “outperform” rating and a $28.00 price target for the company.
View Our Latest Research Report on STVN
Hedge Funds Weigh In On Stevanato Group
Stevanato Group Stock Performance
Shares of STVN opened at €21.34 ($22.23) on Friday. The company has a 50-day moving average of €20.01 and a two-hundred day moving average of €19.76. The stock has a market cap of $6.31 billion, a price-to-earnings ratio of 45.40, a PEG ratio of 10.49 and a beta of 0.59. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. Stevanato Group has a one year low of €16.56 ($17.25) and a one year high of €34.73 ($36.18).
Stevanato Group (NYSE:STVN – Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €277.90 million during the quarter, compared to analyst estimates of €274.36 million. During the same period in the prior year, the business posted $0.16 EPS. The company’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, equities research analysts expect that Stevanato Group will post 0.5 earnings per share for the current year.
Stevanato Group Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
See Also
- Five stocks we like better than Stevanato Group
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Micron Stock Under $100: Seize the AI-Driven Upside
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- How to Calculate Retirement Income: MarketBeat’s Calculator
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.